Second, the authors suggested (p 1130 and p 1134) that since genetic risk factors cannot be eliminated, the importance of PAF in genetic predisposition to disease is undermined. However, this assumption may no longer be tenable because of the advent of a new therapeutic option, epigenetic therapy, which attempts to correct epigenetic defects.
3 An epigenetic drug, 5-azacytidine, has recently been approved by the Food and Drug Administration for the treatment of myelodysplastic syndrome 6 and many other epigenetic drugs are undergoing development. Tables 5 and 6 of our paper, are four successive regression models, in which we addressed three questions: (i) Is maternal smoking during pregnancy associated with children's IQ? (ii) Does low-birthweight mediate the association? (iii) Is the statistical association highly confounded with other factors that influence children's IQ and thus not causal? Results of Model 4, in which the third question is addressed, show that the association between maternal smoking and children's IQ is nearly obliterated and is no longer 
